Sign up to save your podcasts
Or
Share Advances in Minimally Invasive Screening for Lung Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advances in Minimally Invasive Screening for Lung Cancer
Guest: Julie A. Barta, MD, ATSF
Host: Peter J. Mazzone, MD, MPH, FCCP
Lung cancer is most treatable when detected at early stages, yet fewer than 5% of eligible adults are screened using the recommended low-dose CT scan. Blood-based tests for early detection of lung cancer are in development. Join Dr. Peter Mazzone and Dr. Julie Barta as they discuss the latest data on these tests with potential to improve screening rates and outcomes in high-risk individuals.
View all episodes
By ReachMDGuest: Julie A. Barta, MD, ATSF
Host: Peter J. Mazzone, MD, MPH, FCCP
Lung cancer is most treatable when detected at early stages, yet fewer than 5% of eligible adults are screened using the recommended low-dose CT scan. Blood-based tests for early detection of lung cancer are in development. Join Dr. Peter Mazzone and Dr. Julie Barta as they discuss the latest data on these tests with potential to improve screening rates and outcomes in high-risk individuals.